Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Cerevel Therapeutics Holdings Inc.

    World Rank (Jan-05-2024)
    2,079
    Market Cap (Jan-05-2024)
    7.635 Billion USD
    World Rank (Jul-30-2023)
    3,086
    Market Cap (Jul-30-2023)
    4.779 Billion USD
    World Rank (Dec-25-2022)
    2,820
    Market Cap (Dec-25-2022)
    4.805 Billion USD
    World Rank (Jan-07-2022)
    3,528
    Market Cap (Jan-07-2022)
    4.56 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -367 Million USD
    Annual Net Income in USD
    -351 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Cerevel Therapeutics Holdings is a clinical stage biopharmaceutical company that combines a deep understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) receptor pharmacology to discover and develop new therapies. The headquarters is in USA.

  2. Ascendis Pharma A/S

    World Rank (Jan-05-2024)
    2,135
    Market Cap (Jan-05-2024)
    7.414 Billion USD
    World Rank (Jul-30-2023)
    2,847
    Market Cap (Jul-30-2023)
    5.234 Billion USD
    World Rank (Dec-25-2022)
    2,096
    Market Cap (Dec-25-2022)
    6.791 Billion USD
    World Rank (Jan-07-2022)
    2,604
    Market Cap (Jan-07-2022)
    6.65 Billion USD
    Annual Revenue in USD
    56 Million USD
    Annual Operating Income in USD
    -619 Million USD
    Annual Net Income in USD
    -643 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Denmark.
  3. Ionis Pharmaceuticals

    World Rank (Jan-05-2024)
    2,137
    Market Cap (Jan-05-2024)
    7.403 Billion USD
    World Rank (Jul-30-2023)
    2,651
    Market Cap (Jul-30-2023)
    5.694 Billion USD
    World Rank (Dec-25-2022)
    2,556
    Market Cap (Dec-25-2022)
    5.421 Billion USD
    World Rank (Jan-07-2022)
    3,683
    Market Cap (Jan-07-2022)
    4.29 Billion USD
    Annual Revenue in USD
    587 Million USD
    Annual Net Income in USD
    -269 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Biotechnology company with headquarters is in USA.

  4. Exelixis

    World Rank (Jan-05-2024)
    2,140
    Market Cap (Jan-05-2024)
    7.383 Billion USD
    World Rank (Jul-30-2023)
    2,387
    Market Cap (Jul-30-2023)
    6.464 Billion USD
    World Rank (Dec-25-2022)
    2,676
    Market Cap (Dec-25-2022)
    5.106 Billion USD
    World Rank (Jan-07-2022)
    2,857
    Market Cap (Jan-07-2022)
    5.93 Billion USD
    Annual Revenue in USD
    1,611 Million USD
    Annual Operating Income in USD
    201 Million USD
    Annual Net Income in USD
    182 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Exelixis is a Commercially successful and Oncology Focused Biotechnology company. The company established a broad drug discovery and development platform that has served as the foundation for continued efforts to bring new cancer therapies to patients in need. Headquarters is in USA.

  5. Shanghai Raas Blood Products

    World Rank (Jan-05-2024)
    2,164
    Market Cap (Jan-05-2024)
    7.290 Billion USD
    World Rank (Jul-30-2023)
    2,243
    Market Cap (Jul-30-2023)
    6.950 Billion USD
    World Rank (Dec-25-2022)
    2,507
    Market Cap (Dec-25-2022)
    5.519 Billion USD
    World Rank (Jan-07-2022)
    2,449
    Market Cap (Jan-07-2022)
    7.26 Billion USD
    Annual Revenue in USD
    920 Million USD
    Annual Operating Income in USD
    286 Million USD
    Annual Net Income in USD
    263 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in China.
  6. Apellis Pharmaceuticals

    World Rank (Jan-05-2024)
    2,186
    Market Cap (Jan-05-2024)
    7.197 Billion USD
    World Rank (Jul-30-2023)
    3,727
    Market Cap (Jul-30-2023)
    3.729 Billion USD
    World Rank (Dec-25-2022)
    2,468
    Market Cap (Dec-25-2022)
    5.624 Billion USD
    World Rank (Jan-07-2022)
    3,682
    Market Cap (Jan-07-2022)
    4.29 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Net Income in USD
    -652 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Apellis Pharmaceuticals is a Biopharmaceutical company that is committed to leveraging courageous science, creativity and compassion to deliver life changing therapies. The company develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade including those within hematology, ophthalmology, nephrology and neurology. The headquarters is in USA.

  7. Beijing Tiantan Biological Products

    World Rank (Jan-05-2024)
    2,210
    Market Cap (Jan-05-2024)
    7.106 Billion USD
    World Rank (Jul-30-2023)
    2,571
    Market Cap (Jul-30-2023)
    5.897 Billion USD
    World Rank (Dec-25-2022)
    2,650
    Market Cap (Dec-25-2022)
    5.177 Billion USD
    World Rank (Jan-07-2022)
    2,758
    Market Cap (Jan-07-2022)
    6.21 Billion USD
    Annual Revenue in USD
    597 Million USD
    Annual Operating Income in USD
    187 Million USD
    Annual Net Income in USD
    123 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Beijing Tiantan Biological Products is a voluntary public health driven alliance of vaccine manufacturers from developing countries, firmly engaged in research, development, manufacturing and supply of high-quality vaccines that are accessible to protect people against known and emerging infectious diseases globally. The company annual revenue is 466.45 million USD and 3,415 employees as on 2019. The headquarters is in China.
  8. Intra-Cellular Therapies

    World Rank (Jan-05-2024)
    2,318
    Market Cap (Jan-05-2024)
    6.689 Billion USD
    World Rank (Jul-30-2023)
    2,600
    Market Cap (Jul-30-2023)
    5.833 Billion USD
    World Rank (Dec-25-2022)
    2,828
    Market Cap (Dec-25-2022)
    4.796 Billion USD
    World Rank (Jan-07-2022)
    4,331
    Market Cap (Jan-07-2022)
    3.51 Billion USD
    Annual Revenue in USD
    249 Million USD
    Annual Operating Income in USD
    -263 Million USD
    Annual Net Income in USD
    -256 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Intra-Cellular Therapies is a Biopharmaceutical company. It develops innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers. The headquarters is in USA.

  9. BridgeBio Pharma

    World Rank (Jan-05-2024)
    2,350
    Market Cap (Jan-05-2024)
    6.583 Billion USD
    World Rank (Jul-30-2023)
    2,721
    Market Cap (Jul-30-2023)
    5.524 Billion USD
    World Rank (Dec-25-2022)
    7,610
    Market Cap (Dec-25-2022)
    1.178 Billion USD
    World Rank (Jan-07-2022)
    5,962
    Market Cap (Jan-07-2022)
    2.16 Billion USD
    Annual Revenue in USD
    77 Million USD
    Annual Operating Income in USD
    -468 Million USD
    Annual Net Income in USD
    -481 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    BridgeBio Pharma is a biotechnology company that develop and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible. The headquarters is in USA.
  10. Pharmaron Beijing

    World Rank (Jan-05-2024)
    2,420
    Market Cap (Jan-05-2024)
    6.375 Billion USD
    World Rank (Jul-30-2023)
    3,331
    Market Cap (Jul-30-2023)
    4.361 Billion USD
    World Rank (Dec-25-2022)
    1,559
    Market Cap (Dec-25-2022)
    9.803 Billion USD
    World Rank (Jan-07-2022)
    1,364
    Market Cap (Jan-07-2022)
    14.83 Billion USD
    Annual Revenue in USD
    1,169 Million USD
    Annual Net Income in USD
    261 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaron Beijing is a fully Integrated Pharmaceutical Research and Development Service Platform Supporting the life science industries company. It operations in China, the US and the UK staffed by more than 11,000 employees. The headquarters is in China.

Share

Ads